GlobeNewswire
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
📈
AI Sentiment
Highly Positive
8/10
- Home
- TOVX
as of 02-24-2026 3:45pm EST
$0.19
+$0.02
+9.60%
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | ROCKVILLE |
| Market Cap: | 6.4M | IPO Year: | 2012 |
| Target Price: | N/A | AVG Volume (30 days): | 6.0M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.38 | EPS Growth: | -1569.30 |
| 52 Week Low/High: | $0.16 - $1.50 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | -100.00% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.05 | Index: | N/A |
| Free Cash Flow: | -16938000.0 | FCF Growth: | N/A |
AI-Powered TOVX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 70.00%
70.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Theriva Biologics Inc. News
TOVX Breaking Stock News: Dive into TOVX Ticker-Specific Updates for Smart Investing
Compare TOVX vs Leading Stocks
See how TOVX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TOVX Theriva Biologics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.